These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26095468)

  • 1. C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis.
    Mosaad YM; Hammad A; Fawzy Z; El-Refaaey A; Tawhid Z; Hammad EM; Youssef LF; ElAttar EA; Radwan DF; Fawzy IM
    Clin Exp Immunol; 2015 Oct; 182(1):23-34. PubMed ID: 26095468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of rs172378 C1q gene cluster polymorphism with lupus nephritis in Bulgarian patients.
    Radanova M; Vasilev V; Dimitrov T; Deliyska B; Ikonomov V; Ivanova D
    Lupus; 2015 Mar; 24(3):280-9. PubMed ID: 25326229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis.
    Sayed SK; Galal SH; Herdan OM; Mahran AM
    Egypt J Immunol; 2014; 21(2):9-21. PubMed ID: 25812349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predisposition of IL-1β (-511 C/T) polymorphism to renal and hematologic disorders in Indian SLE patients.
    Umare V; Pradhan V; Rajadhyaksha A; Ghosh K; Nadkarni A
    Gene; 2018 Jan; 641():41-45. PubMed ID: 29032148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
    Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
    Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis.
    Hammad A; Mosaad YM; Hammad EM; Elhanbly S; El-Bassiony SR; Al-Harrass MF; Eid R; Sharaf Eldein OA; Alsawah GA; Yahia S; Fawzy IM
    Autoimmunity; 2016; 49(1):31-40. PubMed ID: 26515887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of interleukin-17A gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multi-centre study.
    Elkoumi MA; Allah MA; Mohamed FY; Boraey NF; Abdellatif SH; Shehab MM; Sherif AH; Akeel NE; Saleh RM; Elshreif AM; Abdelrahman HM; Soliman AA; Emam AA; Youssef MA; Fahmy DS; Sallam MM; Nawara AM; Elgohary EA; Ismael A; El-Kaffas SM; Sobeih AA; Ibrahim LM; Ibrahim MA; Abdou AM; Yousry SM; Osman SF; El-Deeb FM; Elhewala AA; Hafez SF; Waked NM; Elbasyouni HA; Fouad RA; Zeidan NM; Nashat M; Farghaly MA
    Lupus; 2020 Jun; 29(7):767-775. PubMed ID: 32380889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
    Metwally IM; Eesa NN; Yacoub MH; Elsman RM
    Adv Rheumatol; 2019 Mar; 59(1):10. PubMed ID: 30832710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
    Gargiulo Mde L; Gómez G; Khoury M; Collado MV; Suárez L; Álvarez C; Sarano J
    Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus.
    Hammad A; Mossad YM; Nasef N; Eid R
    Lupus; 2017 Jul; 26(8):871-880. PubMed ID: 28059021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.
    Rianthavorn P; Chokedeemeeboon C; Deekajorndech T; Suphapeetiporn K
    Lupus; 2013 Jun; 22(7):721-6. PubMed ID: 23640982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
    Elshweikh SA; Elkhouly RM; Shaalan MM; Shorbagy SH
    Egypt J Immunol; 2014; 21(2):49-59. PubMed ID: 25812352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between C1q, TRAIL, and Tim-1 Gene Polymorphisms and Systemic Lupus Erythematosus.
    Yu Y; Zhu C; Zhou S; Chi S
    Genet Test Mol Biomarkers; 2018 Sep; 22(9):546-553. PubMed ID: 30183357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.